DSM-Firmenich AG vs IMCD N.V.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- DSM-Firmenich AG is the larger company by market value: $25.8 B against $6.7 B for IMCD N.V., 3.8 times as much (market caps of Aug 1, 2026). DSM-Firmenich AG's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. IMCD N.V.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- DSM-Firmenich AG had more revenue: $10.7 B against $5.7 B for IMCD N.V., both in the year to December 2025.
- IMCD N.V. made a net profit of $258 M, while DSM-Firmenich AG made a net loss of $1.3 B.
- IMCD N.V. keeps more of each dollar of sales: a net margin of 4.6% against -12.0% for DSM-Firmenich AG.
- DSM-Firmenich AG employs more people: 29,000 against 4,300 at IMCD N.V. Each employee brings in about $369,445 of revenue at DSM-Firmenich AG and $1,318,033 at IMCD N.V.
- DSM-Firmenich AG's revenue grew faster in its latest fiscal year: +20.6% against +6.5% for IMCD N.V.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | DSM-Firmenich AG DSFIR.AS · #973 in the world | IMCD N.V. IMCD.AS · #2,892 in the world |
|---|---|---|
| Profile | ||
| Country | 🇳🇱 Netherlands | 🇳🇱 Netherlands |
| Sector | Basic Materials | Basic Materials |
| Industry | Chemicals | Chemicals |
| Founded | 1902 | 1995 |
| Size | ||
| Market cap | $25.8 B | $6.7 B |
| Revenue | $10.7 B | $5.7 B |
| Net income | $-1.3 B | $258 M▲ best |
| Employees | 29,000 | 4,300 |
| Valuation | ||
| P/E ratio | — | 26.1× |
| Price to sales | 2.4× | 1.2× |
| Price to book | 1.2× | 2.8× |
| Free cash flow yield | 4.8%▲ best | 4.3% |
| Profitability | ||
| Gross margin | 33.2% | — |
| Operating margin | 4.4% | 9.0%▲ best |
| Net margin | 2.2% | 5.9%▲ best |
| Return on equity | 1.2% | 14.3%▲ best |
| Growth | ||
| Revenue growth | 20.6%▲ best | 6.5% |
| Earnings per share growth | -89.7% | -5.2%▲ best |
| Cash | ||
| Free cash flow margin | 8.8%▲ best | 5.6% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Aug 2026; ratios FY2024 | Market cap Aug 2026; ratios FY2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, DSM-Firmenich AG or IMCD N.V.?
DSM-Firmenich AG is the larger company by market value: $25.8 B against $6.7 B for IMCD N.V., 3.8 times as much (market caps of Aug 1, 2026). DSM-Firmenich AG's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. IMCD N.V.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, DSM-Firmenich AG or IMCD N.V.?
DSM-Firmenich AG had more revenue: $10.7 B against $5.7 B for IMCD N.V., both in the year to December 2025. IMCD N.V. made a net profit of $258 M, while DSM-Firmenich AG made a net loss of $1.3 B.
Which is more profitable, DSM-Firmenich AG or IMCD N.V.?
IMCD N.V. keeps more of each dollar of sales: a net margin of 4.6% against -12.0% for DSM-Firmenich AG.
Which has more employees, DSM-Firmenich AG or IMCD N.V.?
DSM-Firmenich AG employs more people: 29,000 against 4,300 at IMCD N.V. Each employee brings in about $369,445 of revenue at DSM-Firmenich AG and $1,318,033 at IMCD N.V.
Which is growing faster, DSM-Firmenich AG or IMCD N.V.?
DSM-Firmenich AG's revenue grew faster in its latest fiscal year: +20.6% against +6.5% for IMCD N.V.
More about DSM-Firmenich AG
More about IMCD N.V.
Sources#
Every figure on this page comes from these, with the date shown next to it.